All about product
Specification
Reviews0
Questions0
Out Of Stock
Product Code: EU14346
Brand: Cipla
Reviews:
0
78.00€
Specifications:
(See all)
Active substance
Imatinib
Also known as
STI571
Blood pressure
Can cause changes in blood pressure, monitoring advised
Chemical name
4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide
Dosage (medical)
Typically 400-800 mg per day, depending on the condition being treated
Features
Active substance
Imatinib
Also known as
STI571
Blood pressure
Can cause changes in blood pressure, monitoring advised
Chemical name
4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide
Dosage (medical)
Typically 400-800 mg per day, depending on the condition being treated
Dosage (sports)
Not applicable as it is not used for performance enhancement
Effects
Treats certain types of cancer by blocking the action of the abnormal protein that signals cancer cells to multiply
Formula
C29H31N7O
Half-life
Approximately 18 hours
Hepatotoxicity
Low, but liver function tests are recommended
Lab Test
Monitoring of complete blood counts and liver function tests are advised
Main action
Inhibits the Bcr-Abl tyrosine kinase
Side effects
Nausea, vomiting, edema, muscle cramps, musculoskeletal pain, diarrhea, rash, fatigue, abdominal pain
Storage conditions
Store at room temperature, away from moisture and heat
Strength
100mg
Substance class
Tyrosine kinase inhibitor
Trade name
Gleevec (USA), Glivec (Europe and Australia)
Use in sports
None, not used as a performance-enhancing drug
Water Retention
Yes, can cause fluid retention
Manufacturer
Cipla Ltd.
Packing
10 tabs/blister
There are no reviews for this product, be the first to leave your review.
No questions about this product, be the first and ask your question.
Imatib 100 mg Cipla
78.00€
